Yoshihito Kogure, Hiroya Hashimoto, Kentaro Tanaka, Takashi Ninomiya, Nobuhisa Ishikawa, Takeshi Numata, Keiichi Fujiwara, Keita Kudo, Hiroshi Watanabe, Nobuyuki Yamamoto, Masahide Oki, Masafumi Yamaguchi. "A randomized phase III study of pembrolizumab versus pembrolizumab with carboplatin plus pemetrexed for locally advanced or metastatic nonsquamous non–small cell lung cancer with PD-L1 TPS ≥ 50%: LAPLACE-50.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.8554